- An unusual fusion gene EML4-ALK in a patient with congenital mesoblastic nephroma2021 | Second Faculty of Medicine
- Crizotinib - a multitargeted inhibitor as a molecularly targeted treatment in non small cell lung cancer2013 | Publication without faculty affiliation
- Crizotinib - a novel multikinase inhibitor of signalling pathways for treatment in selected patients with non-small cell lung cancwer2013 | Faculty of Medicine in Pilsen
- Lorlatinib in the treatment of non-small cell lung cancer2021 | Publication without faculty affiliation
- Ceritinib - a new hope for patients with ALK-positive translocation of non-small-cell lung cancers2017 | Faculty of Medicine in Pilsen
- Lorlatinib in the treatment of non-small cell lung cancer2020 | First Faculty of Medicine
- Novel therapeutic targets in non-small cell lung cancer2011 | First Faculty of Medicine
- Advanced lung cancer as chronic disease2015 | Faculty of Medicine in Pilsen
- Treatment of ALK positive non-small cell lung cancer2021 | First Faculty of Medicine
- What approach to ALK-positive NSCLC?2020 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Molecular pathology of pulmonary carcinomas2014 | Third Faculty of Medicine
- New treatment options - Non small cell lung cancer with rebuilding EML 4-ALK gene2014 | Faculty of Medicine in Pilsen
- Next Generation Sequencing Analysis and its Benefit for Targeted Therapy of Lung Adenocarcinoma2023 | Faculty of Medicine in Pilsen
- ALK Gene Fusions in Epithelioid Fibrous Histiocytoma: A Study of 14 Cases, With New Histopathological Findings2018 | Faculty of Medicine in Pilsen
- Colorectal Adenocarcinomas Harboring ALK Fusion Genes: A Clinicopathologic and Molecular Genetic Study of 12 Cases and Review of the Literature2020 | Faculty of Medicine in Pilsen, Central Library of Charles University